Announced Tue, 21 Jul · 11:59 IST
Board meeting on 3 Aug 2026 to consider Q1 FY27 results
Results View source PDF
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.2%1-day move
₹2499.00
prior close
₹2471.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.1+0.1+0.2+2.2+0.2+0.8+2.2——————
Up moveDown movePending
AI summary
GSK Pharma has informed BSE and NSE that its Board of Directors will meet on Monday, 3 August 2026 to consider and approve the unaudited financial results for Q1 FY27, the quarter ended 30 June 2026.
Likely market impact
Routine board meeting intimation. Watch for Q1 FY27 results on 3 August for revenue and profit trends.